Block Grant U50CI024408

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is funding a $146,922 research study at Emory University to investigate factors that influence the efficiency of influenza A virus infection. The study aims to examine how the mode of virus exposure (direct vs. airborne) and environmental conditions such as temperature and humidity impact host immune responses and the...

This Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,171,832 to Emory University to conduct research on influenza immune responses. The project aims to leverage systems biology approaches, including multi-omic analyses and machine learning models, to identify novel correlates of protection against influenza beyond neutralizing antibodies. The research will...

This $183,541 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund an investigation into within-household transmission of influenza in low-resource settings. The project aims to quantify the spread of influenza within households and develop a model to assess the effectiveness of interventions like vaccination and masking in mitigating intra-household transmission. The...

This $2,074,701 federal Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports a multi-year research program at Emory University focused on understanding the fundamental biological and physical processes that drive influenza A virus transmission in humans. The key objectives of the research program are to: 1) Define the dynamics of viral load, immune...

This $600,000 project grant awarded by the National Science Foundation (NSF) Social, Behavioral, and Economic Sciences (CFDA 47.075) program aims to enhance influenza forecasting through an integrated platform for user-generated temporal forecasts. The project takes a participatory modeling approach to guide the construction of a human judgment platform that generates temporal forecasts of infectious disease trajectories. The key goals are to: 1) identify the factors and decision-making...

The Indiana State Poultry Association Inc. was awarded a $205,344 cooperative agreement by the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care federal grant program (CFDA 10.025). The purpose of this 1-year agreement is for the association to conduct national surveillance and response activities for avian health, including: Active and passive surveillance sampling for avian influenza in...

This $792,687 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to define the structural features of sialoglycans necessary for influenza virus infection and adaptation across different host species. The primary awardee, the University of Iowa, will utilize CRISPR/Cas9 technology to investigate how the sialoglycan repertoire on human lung cells impacts the replication of influenza...

This Cooperative Agreement award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to develop computational models that can accurately predict the breadth and durability of influenza vaccine-induced immunity. The key objectives are to: 1) capture existing influenza vaccine data and generate new experimental data connecting immune variables to vaccine outcomes; 2) generate...

This Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $1,195,056 to Vanderbilt University to develop and implement computational tools to design broadly protective influenza vaccines. The project aims to leverage machine learning and artificial intelligence to create innovative immunogen candidates that can overcome the limitations of current influenza vaccines...

The federal Cooperative Agreement award U01IP001257, valued at $19,786,074.00 and awarded by the National Center for Immunization and Respiratory Diseases (NCIRD) of the Centers for Disease Control and Prevention (CDC), will fund a 5-year prospective observational study of respiratory virus epidemiology in the greater Boston area. This grant is awarded under the CDC's Public Health Emergency Response: Cooperative Agreement for Emergency Response (CFDA 93.354) program, which supports state,...